On Monday, May 14, 2007, a U.S. federal trademark registration was filed for IMMUVANCE. The USPTO has given the IMMUVANCE trademark serial number of 77179766. The current federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED. The correspondent listed for IMMUVANCE is Nadine P. Flynn of BRISTOL-MYERS SQUIBB COMPANY, TRADEMARK DEPARTMENT, 345 PARK AVENUE NEW YORK NY 10154 . The IMMUVANCE trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for IMMUVANCE is Fiber supplement for infant formula.
Mark Image
Word Mark IMMUVANCE Goods and Services IC 005. US 006 018 044 046 051 052. G & S: therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor IC 042. US 100 101. G & S: scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor
IC 044. US 100 101. G & S: providing health and medical information, and providing health and medical information in the nature of providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; providing a website featuring medical information; providing a website featuring medical information in the field of antibodies for use in targeting the CCR5 cell receptor; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
Mark Drawing Code (0) UNKNOWN Serial Number 88956377 Filing Date June 9, 2020 Current Basis 1B Original Filing Basis 1B Owner (APPLICANT) CytoDyn Inc. CORPORATION DELAWARE Suite 660 1111 Main Street Vancouver WASHINGTON 98660 Attorney of Record Jared M. Barrett Description of Mark The mark consists of a representation of an abstracted antibody on a circular background shown adjacent to the term IMMUVANCE in stylized letters. Type of Mark TRADEMARK. SERVICE MARK Register PRINCIPAL Live/Dead Indicator LIVE
